Rx Palladia 50mg x Single Tablet

PALLADIA tablets are indicated for the treatment of Patnaik grade II or III, recurrent, cutaneous mast cell tumors with or without regional lymph node involvement in dogs. For oral use in dogs only. This item requires a valid veterinarian's prescription. - CAUTIONS/WARNINGS:PALLADIA may cause vascular dysfunction which can lead to edema and thromboembolism including pulmonary thromboembolism. Discontinue drug until clinical signs and clinical pathology have normalized. To assure vasculature homeostasis wait at least 3 days after stopping drug before performing surgery. Do not use in dogs used for breeding or for pregnant or lactating bitches. Potential Side Effects: Diarrhea appetite loss lameness weight loss bloody stool. Serious and sometimes fatal gastrointestinal complications including gastrointestinal perforation have occurred rarely in dogs treated with PALLADIA (see Adverse Reactions). If gastrointestinal ulceration is suspected stop drug administration and treat appropriately. - DIRECTIONS:Administer an initial dosage of 3.25 mg/kg (1.48 mg/lb) body weight orally every other day (see Table 1). Dose reductions of 0.5 mg/kg (to a minimum dose of 2.2 mg/kg (1.0 mg/lb) every other day) and dose interruptions (cessation of PALLADIA for up to two weeks) may be utilized if needed to manage adverse reactions (see Table 2 as well as Warnings and Precautions). Adjust dose based on approximately weekly veterinary assessments for the first 6 weeks and approximately every 6 weeks thereafter. PALLADIA may be administered with or without food. Do not split tablets. - STORAGE/DISPOSAL REQ:Store at controlled room temperature 20 to 25 C (68 to 77 F). - HEIGHT(INCHES): 1.000 - WIDTH(INCHES):1.000 - LENGTH(INCHES):1.000

Dosage & Directions

Administer an initial dosage of 3.25 mg/kg (1.48 mg/lb) body weight orally every other day (see Table 1). Dose reductions of 0.5 mg/kg (to a minimum dose of 2.2 mg/kg (1.0 mg/lb) every other day) and dose interruptions (cessation of PALLADIA for up to two weeks) may be utilized if needed to manage adverse reactions (see Table 2 as well as Warnings and Precautions). Adjust dose based on approximately weekly veterinary assessments for the first 6 weeks and approximately every 6 weeks thereafter. PALLADIA may be administered with or without food. Do not split tablets.

Cautions & Warnings

PALLADIA may cause vascular dysfunction which can lead to edema and thromboembolism including pulmonary thromboembolism. Discontinue drug until clinical signs and clinical pathology have normalized. To assure vasculature homeostasis wait at least 3 days after stopping drug before performing surgery. Do not use in dogs used for breeding or for pregnant or lactating bitches. Potential Side Effects: Diarrhea appetite loss lameness weight loss bloody stool. Serious and sometimes fatal gastrointestinal complications including gastrointestinal perforation have occurred rarely in dogs treated with PALLADIA (see Adverse Reactions). If gastrointestinal ulceration is suspected stop drug administration and treat appropriately.

Storage & Disposal

Store at controlled room temperature 20 to 25 C (68 to 77 F).